Triptorelin pamoate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gloria Picoy [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Triptorelin pamoate is a gonadotropin releasing hormone (GnRH) agonist that is FDA approved for the {{{indicationType}}} of advanced prostate cancer. Common adverse reactions include hot flushes, skeletal pain, impotence and headache.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- Triptorelin pamoate is indicated for the palliative treatment of advanced prostate cancer.
- Dosage:
- Triptorelin pamoate 3.75 mg, 1 injection every 4 weeks
- Triptorelin pamoate 11.25 mg, 1 injection every 12 weeks
- Triptorelin pamoate 22.5 mg, 1 injection every 24 weeks
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Triptorelin pamoate in adult patients.
Non–Guideline-Supported Use
- Central precocious puberty
- Endometrial hyperplasia
- Endometriosis
- Fibrocystic breast changes
- In vitro fertilization
- Uterine leiomyoma
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Safety and effectiveness not established in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Triptorelin pamoate in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Triptorelin pamoate in pediatric patients.
Contraindications
There is limited information regarding Triptorelin pamoate Contraindications in the drug label.
Warnings
There is limited information regarding Triptorelin pamoate Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Triptorelin pamoate Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Triptorelin pamoate Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Triptorelin pamoate Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA): X
There is no FDA guidance on usage of Triptorelin pamoate in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Triptorelin pamoate in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Triptorelin pamoate during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Triptorelin pamoate in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Triptorelin pamoate in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Triptorelin pamoate in geriatric settings.
Gender
There is no FDA guidance on the use of Triptorelin pamoate with respect to specific gender populations.
Race
There is no FDA guidance on the use of Triptorelin pamoate with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Triptorelin pamoate in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Triptorelin pamoate in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Triptorelin pamoate in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Triptorelin pamoate in patients who are immunocompromised.
Administration and Monitoring
Administration
Intramuscular
Monitoring
There is limited information regarding Triptorelin pamoate Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Triptorelin pamoate and IV administrations.
Overdosage
There is limited information regarding Triptorelin pamoate overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Triptorelin pamoate Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Triptorelin pamoate Mechanism of Action in the drug label.
Structure
There is limited information regarding Triptorelin pamoate Structure in the drug label.
Pharmacodynamics
There is limited information regarding Triptorelin pamoate Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Triptorelin pamoate Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Triptorelin pamoate Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Triptorelin pamoate Clinical Studies in the drug label.
How Supplied
There is limited information regarding Triptorelin pamoate How Supplied in the drug label.
Storage
There is limited information regarding Triptorelin pamoate Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Triptorelin pamoate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Triptorelin pamoate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Triptorelin pamoate Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Triptorelin pamoate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- Trelstar Depot
- Trelstar LA
- Trelstar [1]
Look-Alike Drug Names
There is limited information regarding Triptorelin pamoate Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.